Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Safety and Efficacy of New Anticoagulants for the Prevention of Venous Thromboembolism After Hip and Knee Arthroplasty: A Meta-Analysis.

Venker BT, Ganti BR, Lin H, Lee ED, Nunley RM, Gage BF.

J Arthroplasty. 2017 Feb;32(2):645-652. doi: 10.1016/j.arth.2016.09.033. Epub 2016 Oct 5. Review.

PMID:
27823844
2.

Impact of recent guideline changes on aspirin prescribing after knee arthroplasty.

Shah SS, Satin AM, Mullen JR, Merwin S, Goldin M, Sgaglione NA.

J Orthop Surg Res. 2016 Oct 20;11(1):123.

3.
4.

Atomic features of an autoantigen in heparin-induced thrombocytopenia (HIT).

Cai Z, Zhu Z, Greene MI, Cines DB.

Autoimmun Rev. 2016 Jul;15(7):752-5. doi: 10.1016/j.autrev.2016.03.011. Epub 2016 Mar 9. Review.

5.

Associations between venous thromboembolism onset, D-dimer, and soluble fibrin monomer complex after total knee arthroplasty.

Mitani G, Takagaki T, Hamahashi K, Serigano K, Nakamura Y, Sato M, Mochida J.

J Orthop Surg Res. 2015 Nov 10;10:172. doi: 10.1186/s13018-015-0315-4.

6.

Low dose compared to variable dose Warfarin and to Fondaparinux as prophylaxis for thromboembolism after elective hip or knee replacement surgery; a randomized, prospective study.

Bern MM, Hazel D, Deeran E, Richmond JR, Ward DM, Spitz DJ, Mattingly DA, Bono JV, Berezin RH, Hou L, Miley GB, Bierbaum BE.

Thromb J. 2015 Oct 7;13:32. doi: 10.1186/s12959-015-0062-0. eCollection 2015.

7.

Atomic description of the immune complex involved in heparin-induced thrombocytopenia.

Cai Z, Yarovoi SV, Zhu Z, Rauova L, Hayes V, Lebedeva T, Liu Q, Poncz M, Arepally G, Cines DB, Greene MI.

Nat Commun. 2015 Sep 22;6:8277. doi: 10.1038/ncomms9277.

8.

Thromboembolic disease after knee arthroplasty is rare in Southern Iran.

Hossain Shahcheraghi G, Javid M, Arasteh MM.

J Orthop. 2014 Jan 31;12(2):86-91. doi: 10.1016/j.jor.2014.01.003. eCollection 2015 Jun.

9.

Thromboprophylaxis and orthopaedic surgery: options and current guidelines.

Solayar GN, Shannon FJ.

Malays J Med Sci. 2014 May;21(3):71-7.

10.

Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study.

Migita K, Bito S, Nakamura M, Miyata S, Saito M, Kakizaki H, Nakayama Y, Matsusita T, Furuichi I, Sasazaki Y, Tanaka T, Yoshida M, Kaneko H, Abe I, Mine T, Ihara K, Kuratsu S, Saisho K, Miyahara H, Segata T, Nakagawa Y, Kamei M, Torigoshi T, Motokawa S.

Arthritis Res Ther. 2014 Jul 21;16(4):R154. doi: 10.1186/ar4616.

11.

Evidence-base for aspirin as venous thromboembolic prophylaxis following joint replacement.

Jameson SS, Baker PN, Deehan DJ, Port A, Reed MR.

Bone Joint Res. 2014 May;3(5):146-9. doi: 10.1302/2046-3758.35.2000225.

12.

Venous Thromboembolism (VTE) Prophylaxis for Hip and Knee Arthroplasty: Changing Trends.

Budhiparama NC, Abdel MP, Ifran NN, Parratte S.

Curr Rev Musculoskelet Med. 2014 Jun;7(2):108-16. doi: 10.1007/s12178-014-9207-1.

13.

The use of pharmacological prophylaxis against venous thromboembolism in hospitalised patients with severe active ulcerative colitis.

Pleet JL, Vaughn BP, Morris JA, Moss AC, Cheifetz AS.

Aliment Pharmacol Ther. 2014 May;39(9):940-8. doi: 10.1111/apt.12691. Epub 2014 Mar 10.

14.

Anticoagulants: A Review of the Pharmacology, Dosing, and Complications.

Alquwaizani M, Buckley L, Adams C, Fanikos J.

Curr Emerg Hosp Med Rep. 2013 Apr 21;1(2):83-97. Print 2013 Jun.

15.

Thromboembolic prophylaxis in total joint arthroplasty.

Knesek D, Peterson TC, Markel DC.

Thrombosis. 2012;2012:837896. doi: 10.1155/2012/837896. Epub 2012 Sep 16.

16.

The new heparins.

Conners MS 3rd, Money SR.

Ochsner J. 2002 Winter;4(1):41-7. No abstract available.

17.

The efficacy and safety of postoperative autologous transfusion of filtered shed blood and anticoagulant prophylaxis in total knee arthroplasty patients.

Park KH, Lee SR, Jin JM, Moon MS.

Knee Surg Relat Res. 2012 Mar;24(1):14-8. doi: 10.5792/ksrr.2012.24.1.14. Epub 2012 Feb 28.

18.

Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.

Donath L, Lützner J, Werth S, Kuhlisch E, Hartmann A, Günther KP, Weiss N, Beyer-Westendorf J.

Br J Clin Pharmacol. 2012 Dec;74(6):947-58. doi: 10.1111/j.1365-2125.2012.04302.x.

19.

Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW Jr.

Chest. 2012 Feb;141(2 Suppl):e278S-e325S. doi: 10.1378/chest.11-2404.

20.

Reduction of the incidence of development of venous thromboembolism by ultrasound-guided femoral nerve block in total knee arthroplasty.

Asakura Y, Tsuchiya H, Mori H, Yano T, Kanayama Y, Takagi H.

Korean J Anesthesiol. 2011 Nov;61(5):382-7. doi: 10.4097/kjae.2011.61.5.382. Epub 2011 Nov 23.

Supplemental Content

Support Center